Aldeyra Therapeutics Inc., of Lexington, Mass., closed a $7.79 million private placement of common stock and warrants led by Perceptive Advisors LLC, with participation by Knoll Capital, Sphera Global Healthcare Fund, DAFNA Capital and other accredited investors.